abstract |
The invention relates to beta -ketoamide compounds of general formula (I) wherein the groups and radicals A, B, b, X, Y, Z, R<1>, R<2>, R<3>, R<5a> and R<5b> have the designations cited in patent claim 1. The invention also relates to medicaments containing at least one inventive amide. As a result of the MCH receptor antagonistic activity, the inventive medicaments are suitable for treating metabolic disorders and/or eating disorders, especially adipositas, bulimia, anorexia, hyperphagia and diabetes. |